Latest Whitepapers

With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.

Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.

Adeno-associated virus (AAV) has shown great potential as a delivery vector for therapeutic genes and is becoming a tool of choice for many emerging gene therapies.

Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others.

Download this whitepaper to discover how a cell sorter can provide precise sorting while maintaining low droplet charge voltages and also handle very high event and sort rates.

Download this whitepaper to discover how third generation sequencing can identify disease-causing variants with complex genetic etiology, detect SARS-CoV-2 and provide novel genetic insights.

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.

Bioconjugation is the chemical linking of two biomolecules to form a single hybrid that retains the biological activity of each component, yet provides a novel function that is not possible with each individual biomolecule.

Proteins are one of the most vital parts of living organisms with many functions, using the latest proteomics methods it is now possible to understand how protein changes in our body influence health and disease, particularly during ageing.

Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.